University of Ulm
University of Ulm
Ulm, Germany3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 3 | 2026-10-06 | NCT07322003 | |
| Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody | Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a | Recruiting | Phase 3 | 2026-04-28 | NCT05045664 | |
| Disentangling the Effect of Brain Insulin Resistance on Brain Health | Cognition Disorders, Cognitive Dysfunction, Nutritional and Metabolic Diseases, autoimmune disease, cognitive disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, psychiatric disorder, type 1 diabetes mellitus, type 2 diabetes mellitus | Recruiting | Not stated | 2026-02-25 | NCT07374705 |